Creo Medical Group PLC (AIM:CREO)

London flag London · Delayed Price · Currency is GBP · Price in GBX
14.88
-1.13 (-7.03%)
Jun 6, 2025, 4:35 PM GMT+1
-58.68%
Market Cap 59.87M
Revenue (ttm) 4.00M
Net Income (ttm) -28.70M
Shares Out 402.47M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 715,882
Average Volume 2,441,697
Open 15.50
Previous Close 16.00
Day's Range 14.76 - 16.00
52-Week Range 9.22 - 37.20
Beta 0.43
RSI 72.40
Earnings Date May 12, 2025

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 287
Stock Exchange London Stock Exchange AIM
Ticker Symbol CREO
Full Company Profile

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.

Financial Statements

News

There is no news available yet.